CAP member Adam Cloe, MD, FCAP, discusses ALL. r. Cloe emphasizes that this is a last resort, only for patients who experience severe, life-threatening reactions like anaphylaxis, or those who develop severe side effects like pancreatitis or blood clotting. In these instances, there may be no feasible alternatives, and discontinuing the drug becomes the only option.
For the full article click here: Your young adult ALL patient has an E. coli asparaginase allergy; now what?